The BCL-6 co-repressor (BCOR) represses gene transcription by interacting with BCL-6 (refs 1, 2). BCOR mutation is responsible for oculo-facio-cardio-dental (OFCD) syndrome, which is characterized by canine teeth with extremely long roots, congenital cataracts, craniofacial defects and congenital heart disease [3] [4] [5] . Here we show that BCOR mutation increased the osteo-dentinogenic potential of mesenchymal stem cells (MSCs) isolated from a patient with OFCD, providing a molecular explanation for abnormal root growth. AP-2α was identified as a repressive target of BCOR, and BCOR mutation resulted in abnormal activation of AP-2α. Gain-and loss-of-function assays suggest that AP-2α is a key factor that mediates the increased osteo-dentinogenic capacity of MSCs. Moreover, we found that BCOR maintained tissue homeostasis and gene silencing through epigenetic mechanisms. BCOR mutation increased histone H3K4 and H3K36 methylation in MSCs, thereby reactivating transcription of silenced target genes. By studying a rare human genetic disease, we have unravelled an epigenetic mechanism for control of human adult stem cell function.
. Here we show that BCOR mutation increased the osteo-dentinogenic potential of mesenchymal stem cells (MSCs) isolated from a patient with OFCD, providing a molecular explanation for abnormal root growth. AP-2α was identified as a repressive target of BCOR, and BCOR mutation resulted in abnormal activation of AP-2α. Gain-and loss-of-function assays suggest that AP-2α is a key factor that mediates the increased osteo-dentinogenic capacity of MSCs. Moreover, we found that BCOR maintained tissue homeostasis and gene silencing through epigenetic mechanisms. BCOR mutation increased histone H3K4 and H3K36 methylation in MSCs, thereby reactivating transcription of silenced target genes. By studying a rare human genetic disease, we have unravelled an epigenetic mechanism for control of human adult stem cell function. OFCD is a rare genetic disorder characterized by teeth with extremely long roots (radiculomegaly), and craniofacial, ocular and cardiac abnormalities [3] [4] [5] [6] [7] . OFCD is inherited in an X-linked dominant pattern in heterozygous females. Males with OFCD cannot survive because of embryonic lethality. Frequent ocular anomalies include congenital cataracts and microphthalmia. Facial deformities include long narrow face, high nasal bridge and cleft palate. Congenital cardiac abnormalities include septal defects and mitral valve defects. Among the many dental defects reported in OFCD patients, enlargement of the roots of canine teeth is the most consistent and typical finding [3] [4] [5] [6] [7] . The roots consist mainly of dentin, a bone-like mineralized tissue that anchors the tooth in alveolar bone. After tooth eruption, root formation is well-synchronized with alveolar bone growth and stops growing at certain ages [8] [9] [10] [11] . By contrast, in OFCD patients, the roots of mandibular incisors and canines can grow continuously until they reach the lower border of the mandible; the roots of maxillary incisors and canines can extend to the cortical plate of the orbit. Thus, canine radiculomegaly has been considered to be an important sign in the diagnosis of OFCD [3] [4] [5] [6] [7] . Genetic studies have found that mutations in BCOR are responsible for OFCD syndrome 3 . Mutations in BCOR, usually truncation and frameshift mutations, result in premature termination of the protein with deletion of the carboxy-terminal domain [3] [4] [5] . BCOR was originally identified as a co-repressor of the transcription repressor BCL-6 (ref. 1) . Chromosomal translocations of BCL-6 are common genomic alterations in non-Hodgkin's B-cell lymphomas 12 . BCOR has been found to interact with histone deacetylase (HDAC), demethylase and H2A ubiquitin ligase, suggesting that BCOR might mediate repression through chromatin modification 1, 13, 14 . In mice, Bcor has been found to be expressed in the tooth primordium, eye, neural tube and branchial arches, which correlate with tissues affected in OFCD patients 15 . Genetic studies, through deleting Bcor in embryonic stem cells, suggest that Bcor has an important role in early mouse embryonic development 16 . MSCs were originally isolated from bone marrow and are multipotent as they can differentiate into a variety of cell types including osteoblasts, chondrocytes, myocytes and adipocytes. Increasing evidence indicates that MSCs are also present in non-bone marrow tissues [17] [18] [19] [20] [21] . Recently, a new population of MSCs has been isolated from dental and craniofacial tissues on the basis of their stem cell properties 11, 22, 23 . These cells are multipotent, osteo-dentinogenic and capable of self-renewal. When transplanted into immunocompromised mice, they generated bone/dentin-like mineralized tissue and were capable of repairing dental and craniofacial defects 11, 24 . Characterization of MSCs from the root apical papilla strongly suggests that these cells are responsible for root dentin formation and root growth. As patients with OFCD have enlarged and continuously growing roots, BCOR mutation could have an intrinsic effect on the proliferation and function of MSCs from the root apical papilla. To test our hypothesis, we isolated MSCs from the root apical papilla of an OFCD patient and examined their stem cell properties. BCOR mutation did not affect expression of stem cell markers, but resulted in enhanced osteo-dentinogenic potential of MSCs by inducing AP-2α. Mechanistically, we found that BCOR mutation increased histone H3K4 and H3K36 methylation, and reduced binding of BCL-6 to the AP-2α promoter, thereby resulting in a loss of BCL-6/ BCOR repressive function. Our results provide a molecular explanation for the abnormal root growth seen in OFCD syndrome. MSCs were isolated from the apical papilla of an OFCD patient with radiculomegaly undergoing surgical removal of the root apex. This patient had a single nucleotide deletion, c.2613delC, resulting in a frameshift mutation with a premature stop codon, p.F871Lfs8X 4 . As with many of the mutations found in other patients with OFCD, this frameshift mutation led to deletion of the BCOR carboxy terminus (approximately 800 amino acid deletion). MSCs isolated from the OFCD patient (MSC-O) proliferated at a faster rate in vitro than wild-type MSCs isolated from a healthy individual (MSC-WT; Fig. 1a ; Supplementary Information, Fig. S1a) . Notably, expression levels of BCOR mRNA in MSC-WT and MSC-O cells were similar ( Supplementary Information, Fig. S1b, c) . Increased proliferation could not fully account for the phenotype of OFCD, as radiculomegaly indicated that the root was heavily mineralized. Thus, we further examined whether BCOR mutation intrinsically affected MSC function. FACS profiling showed that MSC-O cells expressed stem cell markers of MSCs that were similar to those of MSC-WT cells (Fig. 1b ) 11, 20, 21 . Root dentin is a specialized mineralized tissue similar to bone 8, 10, 11 . As root formation is abnormal in patients with OFCD, we tested whether MSC-O cells had increased osteo-dentinogenic potential. MSC-O and MSC-WT cells were treated with differentiation-inducing medium containing dexamethasone, ascorbic acid and β-glycerophosphate, as described previously 11 . To minimize the effect of cell growth on differentiation, MSC-O and MSC-WT cells were plated under confluent conditions. Soon after induction, alkaline phosphatase (ALP) activity, an early marker for osteo-dentinogenic differentiation, was more strongly induced in MSC-O cells, compared with MSC-WT cells (Fig. 1c) . Three weeks after induction, Alizarin Red staining revealed that calcium deposition or mineralization was also significantly higher in MSC-O cells than in MSC-WT cells (Fig. 1d) . Consistently, real-time RT-PCR showed that genes, including OCN and SPP1, which encode extracellular matrix proteins of bone and dentin, were more strongly induced in MSC-O cells, compared with MSC-WT cells (Fig. 1e, f) . Dental sialoprotein (DSP) is an extracellular matrix protein highly expressed in dentin, compared with other tissues 8, 10, 25 . We found that induction of DSP was significantly higher in MSC-O cells than in MSC-WT cells (Fig. 1g) . In vivo transplantation experiments also demonstrated that MSC-O cells generated more bone/dentin-like mineralized tissue, compared with MSC-WT cells (Fig. 1h) .
As OFCD is an X-linked dominant syndrome in heterozygous females, the initial MSC-O cells from the patient could be a mixed population expressing wild-type or mutant BCOR mRNA because of X-inactivation. Thus, it is important to determine whether enhanced osteo-dentinogenic differentiation in passaged MSC-O cells is mainly due to cells expressing mutant BCOR mRNA. Total RNA from MSC-O cells was extracted and RT-RCR was performed using specific primers that were from different exons and spanned the mutation site of BCOR. The PCR products were subcloned into a TA clone vector and sequenced. We found that most of the clones (52 out of 60) expressed mutant BCOR (Supplementary Information, ( Supplementary Information, Fig. S2 ). Moreover, knockdown of BCOR in MSCs isolated from the dental pulp, also known as dental pulp stem cells (DPSCs) 26 , markedly enhanced osteo-dentinogenic differentiation ( Supplementary Information, Fig. S3 ). To determine whether the enhanced osteo-dentinogenic potential associated with MSC-O cells was directly due to BCOR mutation, we tested whether the restoration of wild-type BCOR (isoform C) in MSC-O could inhibit the osteo-dentinogenic potential of MSC-O cells. To rule out clonal variation, MSC-O cells were transduced with retroviruses expressing Flag-BCOR and control vector. Using specific primers to detect Flag-BCOR, RT-PCR confirmed that wild-type BCOR was stably expressed in MSC-O (MSC-O/BCOR) cells, but not in control cells (MSC-O/GFP) (Fig. 2a) . Real-time RT-PCR showed a 5-fold increase in BCOR mRNA expression in MSC-O/BCOR cells, compared with MSC-O/GFP cells (Fig. 2b) , using primers which detect both endogenous BCOR and ectopic Flag-BCOR. Overexpression of wild-type BCOR significantly inhibited proliferation of MSC-O cells (Fig. 2c) . Restoration of wild-type BCOR in MSC-O cells strongly inhibited ALP activity when differentiation was induced (Fig. 2d) . Consistently, mineralization was markedly inhibited in MSC-O/BCOR cells, compared with MSC-O/GFP cells, as determined by Alizarin Red staining (Fig. 2e) .
Our studies suggest that BCOR mutation has intrinsic effects on the differentiation capacity of MSCs. However, because BCOR mutation increases cell proliferation, the enhancement of osteo-dentinogenic potential of MSCs might be an indirect effect. To resolve this crucial issue, we performed gene expression profiling to identify the BCOR target genes that might be associated with osteo-dentinogenic potential using Affymetrix Human Genome U133 Plus 2.0 Array. Together with this information, gain-and loss-of-function experiments would help to determine whether BCOR-regulated target genes were crucial for enhanced osteo-dentinogenic potentials, thereby providing direct evidence to verify the functional role of BCOR mutation in osteodentinogenic capacity. Importantly, microarray revealed that AP-2α was the second highest differentially expressed gene in MSC-O cells, compared with MSC-WT cells (Fig. 3a) . Other genes that are highly expressed in MSC-O cells (>5-fold) relative to MSC-WT cells are listed in Supplementary Information, Table S1 . Previously, genetic studies showed that AP-2α was associated with craniofacial development and that AP-2α knockout caused craniofacial and skeletal defects 27, 28 . RT-PCR confirmed that AP-2α was strongly expressed in MSC-O cells, but not in MSC-WT cells (Fig. 3b) . Consistently, western blot analysis showed that AP-2α was highly expressed in MSC-O cells, but was only barely detectable in MSC-WT cells (Fig. 3c) . Furthermore, we found that AP-2α was not expressed in MSCs from three different healthy individuals, indicating that the difference was unlikely to be caused by individual variation (Fig. 3d) .
To determine whether AP-2α is a key mediator for enhanced osteo-dentinogenic potential resulting from BCOR mutation, we first tested whether overexpression of AP-2α would potentiate the differentiation capacity of MSC-WT cells. To avoid clonal variation, MSC-WT cells were transduced with retroviruses expressing Flag-AP-2α or control vector. Western blot analysis confirmed that AP-2α was expressed (Fig. 3c) . Overexpression of AP-2α did not affect MSC proliferation (Fig. 3e) . We found that overexpression of AP-2α significantly enhanced ALP activity and mineralization on induction (Fig. 3f, g ). Real-time RT-PCR and western blot analysis also revealed that overexpression of AP-2α enhanced expression of OCN, SPP1 and DSP (Fig. 3h-j) .
To further confirm that AP-2α was responsible for the enhanced osteo-dentinogenic potential of MSCs, we used shRNA to knockdown AP-2α expression in MSC-O cells. Western blot analysis confirmed that approximately 90% of AP-2α in MSC-O cells were knocked down by retroviruses expressing AP-2α shRNA (Fig. 4a) . Knockdown of AP-2α did not significantly change cell proliferation (Fig. 4b) , but it significantly reduced ALP activity and mineralization in MSC-O cells (Fig. 4c, d) . Consistently, knockdown of AP-2α decreased expression of OCN, SPP1 and DSP (Fig. 4e-g ). We transplanted MSC-O cells expressing AP-2α shRNA (MSC-O/AP-2α shRNA) and MSC-O expressing luciferase shRNA (MSC-O/Luc shRNA) into nude mice. Knockdown of AP-2α also significantly reduced bone/dentin-like tissue formation in vivo (Fig. 4h) .
RT-PCR and western blot analysis showed that overexpression of BCOR suppressed AP-2α expression in MSC-O cells (Fig. 5a, b) . Conversely, knockdown of BCOR in MSC-WT cells increased AP-2α expression ( Supplementary Information, Fig. S2b ). These results further confirm that BCOR controls AP-2α expression. We then examined whether BCOR was associated with the AP-2α promoter in MSC cells. A BCL-6-binding site (TTTAGGAA), which is located 1,439 bp upstream of the transcription start site, was found on the AP-2α promoter. Chromatin co-immunoprecipitation (ChIP) assays revealed that BCOR was present at the BCL-6-binding site of AP-2α in MSC-WT cells, but not in MSC-O cells (Fig. 5c) . Notably, anti-BCOR antibodies could not recognize the mutant BCOR proteins in MSC-O cells. As a negative control, BCOR was not detected in a region located in the open reading frame (ORF) of AP-2α. Interestingly, although BCL-6 was expressed at similar levels ( Fig. 5d) , its binding to the AP-2α promoter was reduced in MSC-O cells, compared with MSC-WT cells (Fig. 5e) . Recent studies have shown that the BCOR complex contains polycomb group proteins and JHDM1B/ FBXL10 demethylase 13, 14 . Although the functional role of these molecules in the BCOR complex is not clear, their findings suggest that BCOR might use an epigenetic mechanism to direct gene silencing. Abnormal histone methylation resulting from BCOR mutation might affect BCL-6 binding to the AP-2α promoter. JHDM1B is a histone demethylase that has been shown to demethylate trimethylated Lys 4 or dimethylated Lys 36 on histone 3 (H3K4me3 or H3K36me2) 29, 30 . In general, methylation at H3K4 and H3K36 is associated with transcriptional activation 31, 32 . As the BCOR carboxy terminus is required to interact with these molecules, we hypothesized that BCOR mutation in OFCD might impair recruitment of JHDM1B to chromatin. However, despite our repeated efforts, anti-JHDM1B antibodies that were available were not effective in our ChIP assays. To overcome this problem, we used retroviruses to express HA-JHDM1B in MSC-WT and MSC-O cells (Fig. 5f ) and performed ChIP assays using anti-HA antibodies. HA-JHDM1B on the AP-2α promoter in MSC-WT cells was significantly higher than that in MSC-O cells (Fig. 5g) . Moreover, we directly examined whether BCOR mutation affected H3K4 and H3K36 methylation of the AP-2α promoter in MSCs. ChIP assays revealed that H3K36me2 on the AP-2α promoter in MSC-O cells was 7-fold higher than in MSC-WT cells (Fig. 5i) . H3K4me3 on the AP-2α promoter in MSC-O cells was also significantly increased (Fig. 5j) . To further confirm our results, we overexpressed wild-type and OFCD mutant forms of BCOR (O-BCOR) in MSC-O cells (Fig. 5h) . ChIP assays showed that restoration of wild-type BCOR significantly reduced H3K4me3 and H3K36me2 in MSC-O cells (Fig. 5i, j) . By contrast, overexpression of O-BCOR had no effect on H3K4 or H3K36 methylation in MSC-O cells. Of note, a recent study showed that JHDM1B is an H3K36me2-specific demethylase. H3K4me3 changes might be indirect 33 .
To determine whether the BCOR-JHDM1B complex had a role in the inhibition of MSC function, we used shRNA to knock down JHDM1B ( Supplementary Information, Fig. S4a ) in MSC-WT cells. Depletion of JHDM1B resulted in the induction of AP-2α expression ( Supplementary  Information, Fig. S4b ). and enhanced osteo-dentinogenic differentiation of MSC-WT cells ( Supplementary Information, Fig. S4c-f) . Finally, as the BCOR complex is associated with ubiquitylation of histone H2A, we performed ChIP assays to determine whether BCOR mutation affects ubiquitylation of H2A. ChIP assays revealed that ubiquitylation of H2A was significantly reduced in MSC-O cells, compared with MSC-WT cells ( Supplementary Information, Fig. S5 ).
Our studies provide a possible explanation for dental and craniofacial defects in patients with OFCD. We have shown that BCOR mutation led to the upregulation of AP-2α in MSCs and promoted osteo-dentinogenesis. Mechanistically, BCOR has a crucial role in development and maintenance of homeostasis through epigenetic modification of histone methylation. Under normal conditions, BCOR interacts with JHDM1B and represses gene transcription by inhibiting H3K4 and H3K36 methylation on the target gene promoter in MSCs. In patients with OFCD, the BCOR mutation fails to recruit JHDM1B to the target gene promoter, resulting in increased H3K4 and H3K36 methylation, and transcription activation of silenced gene in MSCs. Supporting this conclusion, depletion of JHDM1B in MSCs also induces AP-2α expression and enhances osteo-dentinogenic differentiation of MSCs. On the basis of our microarray results, the BCOR complex might repress a large number of genes in MSCs. In addition to AP-2α, it is possible that other genes could also have a role in dental and craniofacial defects in patients with OFCD. For example, PAX3, which is associated with craniofacial development, is also activated in MSC-O cells. In addition to craniofacial defects, cataracts are the most frequent ocular phenotype of OFCD patients 3, 4 . Interestingly, transgenic mice overexpressing AP-2α developed cataracts 34 , further supporting the notion that AP-2α has a role in the pathogenesis of OFCD. MSCs are also involved in cardiac development and formation. In future studies, it will be interesting to examine how BCOR mutation affects heart development and whether AP-2α plays a role in congenial heart defects associated with OFCD patients. In summary, by studying a rare human genetic disease, we identified the BCOR complex as a negative regulator of osteo-dentiogenic capacity of MSCs. . For viral infection, MSCs were plated overnight and then infected with retroviruses in the presence of polybrene (6 μg ml -1 , Sigma-Aldrich) for 6 h. The target sequences for shRNA were: AP-2α, 5´-TCCAGGAAGATCTTTAAGA-3´; BCOR, 5´-GATGGCTTCAGTGCTATAT-3´; JHDM1B, 5´-GAGTCAA GACGTAGAATAA3´ and luciferase, 5´-GTGCGTTGC TAGTACCAAC-3´. The shRNA was subcloned into a pSIREN retroviral vector (BD Bioscience) and retrovirus packaging was performed as described previously 35 .
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Methods
Western blot analysis. Cells were lysed in RIPA buffer (10 mM Tris-HCL, 1 mM EDTA, 1% sodium dodecyl sulfate (SDS), 1% Nonidet P-40, 1: 100 proteinase inhibitor cocktail, 50 mM β-glycerophosphate, 50 mM sodium fluoride). The samples were separated on a 10% SDS polyacrylamide gel and transferred to PVDF membrane by a semi-dry transfer apparatus (Bio-Rad). The membranes were blotted with 5% milk for 2 h and then incubated with primary antibodies overnight. The immunocomplexes were incubated with horseradish peroxidase-conjugated anti-rabbit or antimouse IgG (Promega) and visualized with SuperSignal reagents (Pierce). Primary antibodies were purchased from the following commercial sources: monoclonal antibodies against AP-2α (1:200), polyclonal antibodies against HSP90 and TFIIB (1:1,000; Santa Cruz); monoclonal antibodies against ubiquitylated H2A (1:500; Millipore); polyclonal antibodies against H3K4me3 (1:500; Abcam) and H3K36me2 (1:500; Upstate); polyclonal antibodies against dentin sialoprotein (DSP; 1:1,000; NIDCR/NIH, USA); polyclonal anti-BCL-6 antibodies (1:1,000; Cell Signaling); monoclonal antibodies against α-tubulin (1:100,000; Sigma-Aldrich).
ALP and Alizarin Red staining. MSCs were grown in mineralization-inducing medium containing 100 μM ascorbic acid, 2 mM β-glycerophosphate and 10 nM dexamethasone. For ALP staining, after induction, cells were fixed with 70% ethanol and incubated with a solution of 0.25% naphthol AS-BI phosphate and 0.75% Fast Blue BB dissolved in 0.1 M Tris buffer (pH 9.3). ALP activity assay was performed with an ALP kit according to the manufacturer's protocol (Sigma-Aldrich) and normalized on the basis of protein concentrations. To assess mineralization, cells were induced for 2-3 weeks, fixed with 70% ethanol and stained with 2% Alizarin Red (Sigma-Aldrich). To quantitatively determine calcium mineral density, Alizarin Red was destained with 10% cetylpyridinium chloride in 10 mM sodium phosphate for 30 min at room temperature. The concentration was determined by absorbance measurement at 562 nm on a multiplate reader using a standard calcium curve prepared in the same solution. The final calcium levels in each group were normalized with the total protein concentrations prepared from duplicate plates 20 .
Reverse transcriptase-polymerase chain reaction (RT-PCR) and realtime RT-PCR. Total RNA was isolated from MSCs using Trizol reagents (Invitrogen). The primers used were: AP-2α, forward, 5´-CTCTCACCAC CCGAGTGTCT-3´ and reverse, 5´-GAGGTTGAAGTGGGTCAAGC-3´; BCOR, forward, CTCAGGAGACCACCCAGTC-3´ and reverse, 5´-CCCT GAGCCACAGATACTTG3´; glyceraldehyde-3-phosphate dehydrogenase (GAPDH) , forward, 5´-GATCATCAGCAATGCCTCCT-3´ and reverse, 
